Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ebstein's anomaly in infants].

M Maas Enriquez, F Attie, L Muñoz Castellanos

    Archivos Del Instituto De Cardiologia De Mexico
    |September 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Population pharmacokinetic characterization of BAY 81-8973, a full-length recombinant factor VIII: lessons learned - importance of including samples with factor VIII levels below the quantitation limit.

    Haemophilia : the official journal of the World Federation of Hemophilia·2017
    Same author

    Efficacy and safety of BAY 81-8973, a full-length recombinant factor VIII: results from the LEOPOLD I trial.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    BAY 81-8973, a full-length recombinant factor VIII: results from an International comparative laboratory field study.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Chromogenic assay for BAY 81-8973 potency assignment has no impact on clinical outcome or monitoring in patient samples.

    Journal of thrombosis and haemostasis : JTH·2016
    Same author

    Safety and efficacy of BAY 81-8973 for surgery in previously treated patients with haemophilia A: results of the LEOPOLD clinical trial programme.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.

    Haemophilia : the official journal of the World Federation of Hemophilia·2015
    Same journal

    Basis for the therapeutic use of slow absorption penicillin.

    Archivos del Instituto de Cardiologia de Mexico·2010
    Same journal

    Seventeen cases of subacute bacterial endocarditis treated with penicillin.

    Archivos del Instituto de Cardiologia de Mexico·2010
    Same journal

    The evolution of our clinical knowledge on coronary heart disease.

    Archivos del Instituto de Cardiologia de Mexico·2010
    Same journal

    The crossed and ipsilateral extensor spinal reflexes.

    Archivos del Instituto de Cardiologia de Mexico·2010
    Same journal

    Isolated heart work under the action of ouabain, digitalin, digilánnidos, escilarina, nucleosides, adrenaline, ephedrine, metrazol and niketamida.

    Archivos del Instituto de Cardiologia de Mexico·2010
    Same journal

    Senile jugular.

    Archivos del Instituto de Cardiologia de Mexico·2010
    See all related articles

    Ebstein's disease, a congenital tricuspid valve malformation, impacts hemodynamics. Survival is poor for infants with early cyanosis, but improves if they reach one year of age.

    Area of Science:

    • Cardiology
    • Pediatric Cardiology
    • Congenital Heart Disease

    Context:

    • Ebstein's anomaly is a rare congenital heart defect involving malformation of the tricuspid valve.
    • Hemodynamic alterations result from anatomical valve changes, atrial septal defects, and ventricular dysfunction.
    • This study focuses on infants under two years old diagnosed with Ebstein's anomaly.

    Purpose:

    • To analyze the long-term prognosis of Ebstein's anomaly in young children.
    • To identify factors influencing survival rates in this pediatric population.

    Summary:

    • Nineteen patients under two years old with Ebstein's anomaly were followed for up to 16 years.
    • Eight patients died, six were lost to follow-up, and five survived.
    • Early cyanosis and associated lesions were associated with a poor prognosis.

    Related Experiment Videos

    Impact:

    • The findings highlight the critical importance of early diagnosis and management of Ebstein's anomaly in infants.
    • Survival beyond the first year of life significantly improves the long-term outlook for affected children.
    • This research contributes to understanding the natural history and prognostic indicators for pediatric Ebstein's anomaly.